{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:34:13Z","timestamp":1785886453373,"version":"3.56.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,19]]},"DOI":"10.7759\/cureus.58590","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T14:09:50Z","timestamp":1713535790000},"source":"Crossref","is-referenced-by-count":2,"title":["A Case of Risperidone-Induced Urinary Incontinence"],"prefix":"10.7759","author":[{"given":"Allison C","family":"Eierman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra E","family":"Reischman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V","family":"Gouthro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population","volume":"64","author":"Per\u00e4l\u00e4 J","year":"2007","unstructured":"Per\u00e4l\u00e4 J, Suvisaari J, Saarni SI, et al.. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007, 64:19-28. 10.1001\/archpsyc.64.1.19","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/wps.20994","article-title":"Mortality in people with schizophrenia: A systematic review and meta-analysis of relative risk and aggravating or attenuating factors","volume":"21","author":"Correll CU","year":"2022","unstructured":"Correll CU, Solmi M, Croatto G, et al.. Mortality in people with schizophrenia: A systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022, 21:248-71. 10.1002\/wps.20994","journal-title":"World Psychiatry"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2007.10.005","article-title":"Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950-2005","volume":"98","author":"Capasso RM","year":"2008","unstructured":"Capasso RM, Lineberry TW, Bostwick JM, Decker PA, St Sauver J. Mortality in schizophrenia and schizoaffective disorder: An Olmsted County, Minnesota cohort: 1950-2005. Schizophr Res. 2008, 98:287-94. 10.1016\/j.schres.2007.10.005","journal-title":"Schizophr Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph181910213","article-title":"Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: A systematic review and meta-analysis","volume":"18","author":"Loots E","year":"2021","unstructured":"Loots E, Goossens E, Vanwesemael T, Morrens M, Van Rompaey B, Dilles T. Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: A systematic review and meta-analysis. Int J Environ Res Public Health. 2021, 18:10213. 10.3390\/ijerph181910213","journal-title":"Int J Environ Res Public Health"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson D","year":"1999","unstructured":"Robinson D, Woerner MG, Alvir JM, et al.. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry. 1999, 56:241-7. 10.1001\/archpsyc.56.3.241","journal-title":"Arch Gen Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41537-023-00356-x","article-title":"Influencing factors of medication adherence in schizophrenic patients: A meta-analysis","volume":"9","author":"Guo J","year":"2023","unstructured":"Guo J, Lv X, Liu Y, Kong L, Qu H, Yue W. Influencing factors of medication adherence in schizophrenic patients: A meta-analysis. Schizophrenia (Heidelb). 2023, 9:31. 10.1038\/s41537-023-00356-x","journal-title":"Schizophrenia (Heidelb)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2174\/15734005113096660009","article-title":"Atypicality of atypical antipsychotics revisited","volume":"9","author":"Farah A","year":"2013","unstructured":"Farah A. Atypicality of atypical antipsychotics revisited. Curr Psychiatry Rev. 2013, 9:316-324. 10.2174\/15734005113096660009","journal-title":"Curr Psychiatry Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112027","article-title":"An association between incontinence and antipsychotic drugs: A systematic review","volume":"142","author":"Arasteh A","year":"2021","unstructured":"Arasteh A, Mostafavi S, Vahed SZ, Montazeri SSM. An association between incontinence and antipsychotic drugs: A systematic review. Biomed Pharmacother. 2021, 142:112027. 10.1016\/j.biopha.2021.112027","journal-title":"Biomed Pharmacother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.n146896","article-title":"Second generation antipsychotics & nocturnal enuresis in children","volume":"2","author":"Thiel J","year":"2013","unstructured":"Thiel J. Second generation antipsychotics & nocturnal enuresis in children. Mental Health Clinician. 2013, 2:370-374. 10.9740\/mhc.n146896","journal-title":"Mental Health Clinician"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199409000-00010","article-title":"Clozapine and urinary incontinence","volume":"9","author":"Warner JP","year":"1994","unstructured":"Warner JP, Harvey CA, Barnes TR. Clozapine and urinary incontinence. Int Clin Psychopharmacol. 1994, 9:207-9. 10.1097\/00004850-199409000-00010","journal-title":"Int Clin Psychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.110.087478","article-title":"Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: Comparative cohort study","volume":"199","author":"Harrison-Woolrych M","year":"2011","unstructured":"Harrison-Woolrych M, Skegg K, Ashton J, Herbison P, Skegg DC. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: Comparative cohort study. Br J Psychiatry. 2011, 199:140-4. 10.1192\/bjp.bp.110.087478","journal-title":"Br J Psychiatry"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/3-540-27494-4_4","article-title":"Perception of incontinence in and by society","author":"Enck P","year":"2005","unstructured":"Enck P, Klosterhalfen S. Perception of incontinence in and by society. Urinary and Fecal Incontinence. Becker HD, Stenzl A, Wallwiener D, Zittel TT (ed): Springer , Berlin, Heidelberg; 2005. 33-39. 10.1007\/3-540-27494-4_4"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.11.078","article-title":"Prevalence of urinary incontinence in men, women, and children--current evidence: Findings of the fourth international consultation on incontinence","volume":"76","author":"Buckley BS","year":"2010","unstructured":"Buckley BS, Lapitan MC. Prevalence of urinary incontinence in men, women, and children--current evidence: Findings of the fourth international consultation on incontinence. Urology. 2010, 76:265-70. 10.1016\/j.urology.2009.11.078","journal-title":"Urology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2702.2001.00443.x","article-title":"A review of the psychosocial predictors of help-seeking behaviour and impact on quality of life in people with urinary incontinence","volume":"10","author":"Shaw C","year":"2001","unstructured":"Shaw C. A review of the psychosocial predictors of help-seeking behaviour and impact on quality of life in people with urinary incontinence. J Clin Nurs. 2001, 10:15-24. 10.1046\/j.1365-2702.2001.00443.x","journal-title":"J Clin Nurs"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-013-2276-7","article-title":"Perceptions about female urinary incontinence: A systematic review","volume":"25","author":"Siddiqui NY","year":"2014","unstructured":"Siddiqui NY, Levin PJ, Phadtare A, Pietrobon R, Ammarell N. Perceptions about female urinary incontinence: A systematic review. Int Urogynecol J. 2014, 25:863-71. 10.1007\/s00192-013-2276-7","journal-title":"Int Urogynecol J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/13651500510018329","article-title":"Urinary incontinence in schizophrenic patients treated with atypical antipsychotics: Urodynamic findings and therapeutic perspectives","volume":"9","author":"Torre DL","year":"2005","unstructured":"Torre DL, Isgr\u00f2 S, Muscatello MR, Magno C, Melloni D, Meduri M. Urinary incontinence in schizophrenic patients treated with atypical antipsychotics: Urodynamic findings and therapeutic perspectives. Int J Psychiatry Clin Pract. 2005, 9:116-9. 10.1080\/13651500510018329","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.602","article-title":"The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants, and antipsychotics for the human \u03b11A, \u03b11B, and \u03b11D-adrenoceptors","volume":"8","author":"Proudman RG","year":"2020","unstructured":"Proudman RG, Pupo AS, Baker JG. The affinity and selectivity of \u03b1-adrenoceptor antagonists, antidepressants, and antipsychotics for the human \u03b11A, \u03b11B, and \u03b11D-adrenoceptors. Pharmacol Res Perspect. 2020, 8:e00602. 10.1002\/prp2.602","journal-title":"Pharmacol Res Perspect"},{"key":"ref18","article-title":"Pseudoephedrine for the treatment of clozapine-induced incontinence","volume":"10","author":"Hanes A","year":"2013","unstructured":"Hanes A, Demler TL, Lee C, Campos A. Pseudoephedrine for the treatment of clozapine-induced incontinence. Innov Clin Neurosci. 2013, 10:33-5.","journal-title":"Innov Clin Neurosci"},{"key":"ref19","unstructured":"Bladder control. Medications for urinary problems. (2023). Accessed: February 22, 2024: https:\/\/www.mayoclinic.org\/diseases-conditions\/urinary-incontinence\/in-depth\/bladder-control-problems\/art-20044220."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3843\/GLOWM.10484","article-title":"Lifestyle and behavioral therapies for urinary incontinence","author":"Burgio K","year":"2014","unstructured":"Burgio K. Lifestyle and behavioral therapies for urinary incontinence. Global Library of Women's Medicine. von Dadelszen P (ed): Paula and David Bloomer, London, UK; 2014. 10.3843\/GLOWM.10484"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235380-a-case-of-risperidone-induced-urinary-incontinence","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T14:09:54Z","timestamp":1713535794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235380-a-case-of-risperidone-induced-urinary-incontinence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.58590","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,19]]}}}